PureTech Health Announces Launch of $100M Tender Offer At Premium Price of 250 Pence Per Share
PureTech Health Announces Launch of $100M Tender Offer At Premium Price of 250 Pence Per Share
PureTech Health宣佈以每股250便士的溢價啓動1億美元的要約
- The Company is offering to purchase up to 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) representing approximately 12 percent of the Company's issued ordinary share capital as at 16 May 2024 (being the latest practicable date before publication of this announcement ("Latest Practicable Date")) at a fixed price of 250 pence per Ordinary Share (equivalent to £25.00 per ADS) (the "Tender Price") up to a maximum aggregate amount of $100 million. The maximum amount of $100 million will be translated into a pounds sterling amount on the Ordinary Share Closing Date, and that pounds sterling amount shall determine the maximum number of shares to be accepted for payment in the Tender Offer.
- The Tender Price represents a premium of 25 percent to PureTech's trailing volume weighted average price per Ordinary Share over the three days prior to 19 March 2024, the date of the Company's initial announcement of the Tender Offer proposals and a premium of 12.6 percent to the closing price of 222 pence per Ordinary Share on the Latest Practicable Date.
- 公司提議以每股普通股250便士（相當於每股ADS25.00英鎊）（“投標價格”）（“投標價格”）的固定價格購買多達33,500,000股普通股（包括由ADS代表的普通股）（包括由ADS代表的普通股）（“投標價格”）（“投標價格”），最高總額爲100美元百萬。最高1億美元將在普通股截止日折算成英鎊金額，該英鎊金額將決定要約中接受付款的最大股票數量。
- 投標價格比PureTech在2024年3月19日（公司首次公佈要約提案之日）之前的三天內，每股普通股的過往成交量加權平均價格溢價25％，與最遲可行日期每股普通股222便士的收盤價相比溢價12.6％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。